Cargando…

Prevalence and type of artefact with spectral domain optical coherence tomography macular ganglion cell imaging in glaucoma surveillance

PURPOSE: The ganglion cell analysis (GCA) of the CIRRUS(TM) HD-OCT (Carl Zeiss, Meditec; Dublin, CA) provides measurement of the macular ganglion cell-inner plexiform layer (GCIPL) thickness. This study determined the frequency of scan artefacts and errors in GCIPL imaging in individuals undergoing...

Descripción completa

Detalles Bibliográficos
Autores principales: Awadalla, Mona S., Fitzgerald, Jude, Andrew, Nicholas H., Zhou, Tiger, Marshall, Henry, Qassim, Ayub, Hassall, Mark, Casson, Robert J., Graham, Stuart L., Healey, Paul R., Agar, Ashish, Galanopoulos, Anna, Phipps, Simon, Chappell, Angela, Landers, John, Craig, Jamie E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281246/
https://www.ncbi.nlm.nih.gov/pubmed/30517101
http://dx.doi.org/10.1371/journal.pone.0206684
_version_ 1783378807165550592
author Awadalla, Mona S.
Fitzgerald, Jude
Andrew, Nicholas H.
Zhou, Tiger
Marshall, Henry
Qassim, Ayub
Hassall, Mark
Casson, Robert J.
Graham, Stuart L.
Healey, Paul R.
Agar, Ashish
Galanopoulos, Anna
Phipps, Simon
Chappell, Angela
Landers, John
Craig, Jamie E.
author_facet Awadalla, Mona S.
Fitzgerald, Jude
Andrew, Nicholas H.
Zhou, Tiger
Marshall, Henry
Qassim, Ayub
Hassall, Mark
Casson, Robert J.
Graham, Stuart L.
Healey, Paul R.
Agar, Ashish
Galanopoulos, Anna
Phipps, Simon
Chappell, Angela
Landers, John
Craig, Jamie E.
author_sort Awadalla, Mona S.
collection PubMed
description PURPOSE: The ganglion cell analysis (GCA) of the CIRRUS(TM) HD-OCT (Carl Zeiss, Meditec; Dublin, CA) provides measurement of the macular ganglion cell-inner plexiform layer (GCIPL) thickness. This study determined the frequency of scan artefacts and errors in GCIPL imaging in individuals undergoing HD-OCT surveillance for glaucoma. METHOD: A total of 1439 eyes from 721 subjects enrolled in a prospective study assessing predictors of glaucoma progression underwent macular GCIPL imaging with the CIRRUS HD-OCT at recruitment. The prevalence of acquisition errors, segmentation errors, and co-morbid macular pathology was determined. RESULTS: A total of 87 (6.0%) of the 1439 scans had either acquisition errors, segmentation artefacts, or other macular pathology. The most common co-morbid macular pathology was epiretinal membrane in 2.2% of eyes. CONCLUSION: The macular GCIPL scan was artefact free in 94% of eyes. However, epiretinal membrane and high myopia can cause scan artefact and should be considered when interpreting the results.
format Online
Article
Text
id pubmed-6281246
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-62812462018-12-20 Prevalence and type of artefact with spectral domain optical coherence tomography macular ganglion cell imaging in glaucoma surveillance Awadalla, Mona S. Fitzgerald, Jude Andrew, Nicholas H. Zhou, Tiger Marshall, Henry Qassim, Ayub Hassall, Mark Casson, Robert J. Graham, Stuart L. Healey, Paul R. Agar, Ashish Galanopoulos, Anna Phipps, Simon Chappell, Angela Landers, John Craig, Jamie E. PLoS One Research Article PURPOSE: The ganglion cell analysis (GCA) of the CIRRUS(TM) HD-OCT (Carl Zeiss, Meditec; Dublin, CA) provides measurement of the macular ganglion cell-inner plexiform layer (GCIPL) thickness. This study determined the frequency of scan artefacts and errors in GCIPL imaging in individuals undergoing HD-OCT surveillance for glaucoma. METHOD: A total of 1439 eyes from 721 subjects enrolled in a prospective study assessing predictors of glaucoma progression underwent macular GCIPL imaging with the CIRRUS HD-OCT at recruitment. The prevalence of acquisition errors, segmentation errors, and co-morbid macular pathology was determined. RESULTS: A total of 87 (6.0%) of the 1439 scans had either acquisition errors, segmentation artefacts, or other macular pathology. The most common co-morbid macular pathology was epiretinal membrane in 2.2% of eyes. CONCLUSION: The macular GCIPL scan was artefact free in 94% of eyes. However, epiretinal membrane and high myopia can cause scan artefact and should be considered when interpreting the results. Public Library of Science 2018-12-05 /pmc/articles/PMC6281246/ /pubmed/30517101 http://dx.doi.org/10.1371/journal.pone.0206684 Text en © 2018 Awadalla et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Awadalla, Mona S.
Fitzgerald, Jude
Andrew, Nicholas H.
Zhou, Tiger
Marshall, Henry
Qassim, Ayub
Hassall, Mark
Casson, Robert J.
Graham, Stuart L.
Healey, Paul R.
Agar, Ashish
Galanopoulos, Anna
Phipps, Simon
Chappell, Angela
Landers, John
Craig, Jamie E.
Prevalence and type of artefact with spectral domain optical coherence tomography macular ganglion cell imaging in glaucoma surveillance
title Prevalence and type of artefact with spectral domain optical coherence tomography macular ganglion cell imaging in glaucoma surveillance
title_full Prevalence and type of artefact with spectral domain optical coherence tomography macular ganglion cell imaging in glaucoma surveillance
title_fullStr Prevalence and type of artefact with spectral domain optical coherence tomography macular ganglion cell imaging in glaucoma surveillance
title_full_unstemmed Prevalence and type of artefact with spectral domain optical coherence tomography macular ganglion cell imaging in glaucoma surveillance
title_short Prevalence and type of artefact with spectral domain optical coherence tomography macular ganglion cell imaging in glaucoma surveillance
title_sort prevalence and type of artefact with spectral domain optical coherence tomography macular ganglion cell imaging in glaucoma surveillance
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281246/
https://www.ncbi.nlm.nih.gov/pubmed/30517101
http://dx.doi.org/10.1371/journal.pone.0206684
work_keys_str_mv AT awadallamonas prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance
AT fitzgeraldjude prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance
AT andrewnicholash prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance
AT zhoutiger prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance
AT marshallhenry prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance
AT qassimayub prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance
AT hassallmark prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance
AT cassonrobertj prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance
AT grahamstuartl prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance
AT healeypaulr prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance
AT agarashish prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance
AT galanopoulosanna prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance
AT phippssimon prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance
AT chappellangela prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance
AT landersjohn prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance
AT craigjamiee prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance